Series 63 – Uniform Securities Agent State Law Exam
The Series 63 exam — the Uniform Securities State Law Examination — is a North American Securities Administrators Association (NASAA) exam administered by FINRA.
The exam consists of 60 scored questions. Candidates have 75 minutes to complete the exam. In order for a candidate to pass the Series 63 exam, he/she must correctly answer at least 43 of the 60 scored questions.
For additional information about this exam, including the content outline, please visit the exams page on the NASAA website.
NASAA is in the process of updating questions on the Series 63, 65, and 66 exams in light of the recently enacted SECURE Act. Currently, questions on the exam have not been modified and are based on the status of the law as of 12/31/2019. NASAA will update this website when it has completed its review, made any necessary changes, and has a planned switchover date.
COVID-19 Guidance on FINRA-Administered Exams
FINRA and Prometric take the health and well-being of our community as a top priority. In response to the recent guidance from the US Centers for Disease Control and Prevention (CDC) related to the growing concerns about the Coronavirus (COVID-19), Prometric is closing its testing centers in the United States and Canada for a period of 30 days, starting March 18, 2020. Candidates who have an existing appointment will receive an email from Prometric with instructions on how to reschedule their appointment to a future date; rescheduling fees will not be applied. To change an existing appointment scheduled over 30 days (April 16 or later) or to schedule a new appointment, please access the Prometric website.
Additionally, FINRA is aware of the challenges that COVID-19 is presenting for our candidates who want to take exams. FINRA will extend all enrollment windows that are currently open and scheduled to expire by the end of May. Each FINRA-administered exam enrollment end date will be extended through the same end date of May 31, 2020.
Please visit FINRA’s COVID-19 / Coronavirus page for complete updates and guidance.